Category: 3. Business

  • Three Priorities for a New Age of Electricity Load Growth

    Three Priorities for a New Age of Electricity Load Growth

    We are in a new age of electricity demand. As the recent International Energy Agency (IEA) report reminds us, electricity demand is seeing some of its highest growth rates in the past decade. Headlines keep coming on how data centers are to blame. While this may be true in some local cases, most of the world has many demand sources that are rising together in parallel. As electricity costs rise for everyday people, it’s important to focus on three key solutions: fast, flexible capacity; a stronger grid; and energy efficiency.

    The world is adding a Japan-sized amount of electricity demand every year — nearly half of that from China alone. However, the sources of load growth differ substantially. In developed regions like the United States and Europe, most new demand will come from data centers and electric vehicles, according to the latest analysis from Bloomberg New Energy Finance (BNEF). Yet in fast-growing Asia and Africa, a strong majority of growth will come from buildings, as cities grow and citizens gain access to essential appliances (such as air conditioners under increasing extreme heat). Industrial sources are also crucial, especially in China, where electrification is happening faster than anywhere.

    All this growth comes with real risks of rising costs. Wholesale electricity prices in the United States and Europe have risen by 30–40 percent in the past year alone, largely due to higher gas prices. Renewable energy can reduce these risks, offering cheaper electricity than fossil fuels in more than 90 percent of new projects. However, barriers to clean supply, from grid constraints to cost of capital issues, are limiting deployment and pushing up prices.

    It’s time to overcome those barriers while scaling complementary solutions. There are many ways to bring on clean capacity in fast, flexible ways — from virtual power plants to low-cost, low-barrier new generation (led by solar and batteries). In parallel, alternative transmission technologies can strengthen the grid, enhancing transmission upgrades and avoiding cost hikes at a much faster rate. Finally, opportunities abound to reduce energy waste and accelerate efficiency across data centers, air conditioners, and other end uses — avoiding demand while raising our wellbeing.

    No matter the sources, electricity load growth is the new reality around the world. It’s time to meet that reality with solutions that can cut costs and bring power to us all.

    Continue Reading

  • Family-run pet shop shuts after more than 60 years

    Family-run pet shop shuts after more than 60 years

    Tom Walker

    BBC News, Liverpool

    BBC Terry has short hair and is wearing a green checked shirt. He is standing with his arm around Orla who has short blonde hair and is wearing glasses and a blue and white striped top. They are both stood at the counter in the pet shop smiling at the camera. BBC

    Terry and Orla Smith say they are looking forward to a restful retirement

    “All good things must come to an end.”

    So says the owner of a family-run pet shop which is closing its doors after more than 60 years.

    Terry Smith took over from his dad as owner of Pet Needs in Wirral in 1980.

    He said he and his wife Orla, who have run the store together for the last 25 years, would miss the customers as they retired.

    “We’ll miss the daily contact with people, customers who have become friends and we will miss the banter,” Mr Smith said.

    “I’ve been here since I left school in 1980, the pet trade business is in the family,” Mr Smith said.

    “Originally my father ran the shop and his grandfather first opened a pet shop in Woodchurch Lane in Birkenhead before he moved to Prenton Road West opposite Tranmere’s ground.”

    Google The frontage of Pet Needs on Liscard Crescent with pet supplies stacked outside the frontGoogle

    Pet Needs on Liscard Crescent was established in the 1960s

    Mrs Smith said the shop on Liscard Crescent had been “incredibly busy” for the past few weeks as word had got around about the closure.

    She said the shop’s success had been down to her husband’s caring nature with customers.

    “He has this way about him that just allows him to connect with people,” she said.

    “To run a pet shop you have to have that gentleness and kindness and he definitely has that.”

    Jo Cunningham has long red hair, she is wearing dark rimmed glasses and a beige trenchcoat. She is stood at the counter holding a bag of purchases.

    Jo Cunningham said she would miss the personal service the shop was known for

    Customer of 50 years Jo Cunningham said she would miss the shop “unbelievably”.

    “There is nothing like Pet Needs anywhere else on the Wirral,” she said.

    “This is an amazing, unique shop. The personal service, the deliveries, the advice, you can just pop in whatever your need to ask them and they are here.”

    Another customer Chris Fog said: “They are so knowledgeable in what they do.

    “There is a personal sense of nothing is too much trouble for them and I’d like to think that they’ve become friends as well.”

    She described the closure as “the end of an era” and wished the couple a “wonderful retirement”.

    Continue Reading

  • Microsoft, Meta Platforms, Carvana, and More

    Microsoft, Meta Platforms, Carvana, and More

    Matthias Balk / picture alliance via Getty Image

    Microsoft benefited from its Azure cloud computing service

    • U.S. equities were mostly higher at midday, with the S&P 500 and Nasdaq trading at record highs, on strong tech earnings.

    • Microsoft and Meta Platforms both beat profit and sales estimates.

    • Align Technology missed forecasts for earnings, revenue, and guidance on consumer caution and macroeconomic concerns.

    The S&P 500 and Nasdaq traded at record highs at midday, boosted by tech earnings news. The  Dow Jones Industrial Average was little changed.

    Shares of Microsoft (MSFT) and Meta Platforms (META) jumped when both tech giants posted better-than-expected results, with Microsoft benefiting from its Azure cloud computing service and Meta Platforms boosted by artificial intelligence product demand.

    EBay (EBAY) was the best-performing stock in the S&P 500 as the online trading site beat profit and sales estimates and gave strong guidance on higher demand for collectables and Pokemon cards.

    Carvana (CVNA) also exceeded earnings and revenue forecasts, and topped unit sales expectations, sending the used car retailer’s shares to all-time high.

    Align Technology (ALGN) shares cratered after the provider of dental devices missed analysts’ estimates for profit, sales, and guidance, which the company blamed on deteriorating consumer sentiment and macroeconomic worries.

    U.S.-listed shares of AB InBev (BUD) tumbled when the world’s biggest beermaker reported second quarter volume and sales that were short of forecasts on soft demand in China and Brazil.

    Baxter International (BAX) shares plunged after the medical products supplier’s earnings were below estimates and it slashed its guidance as the company continues to feel the effects of damage to one of its key manufacturing plants caused by Hurricane Helene.

    Oil and gold futures fell. The yield on the 10-year Treasury note was down. The U.S. dollar gained on the pound and yen, but lost ground to the euro. Prices for most major cryptocurrencies were higher.

    TradingView

    TradingView

    Read the original article on Investopedia

    Continue Reading

  • IEA: Renewables will be world’s top power source ‘by 2026’ – Carbon Brief

    1. IEA: Renewables will be world’s top power source ‘by 2026’  Carbon Brief
    2. The long march of electrification  ember-energy.org
    3. Electricity Mid-Year Update 2025 – Analysis  IEA – International Energy Agency
    4. India’s power demand to rise 4 pc in 2025, renewable energy output surges: IEA  IANS LIVE
    5. Global electricity demand set for robust growth until 2026 despite economic pressures  energynews

    Continue Reading

  • Cellnex consolidates its growth: Organic Revenues up 6%, EBITDAaL up 8.1% and strengthens its financial position through the refinancing of its syndicated loan

    Cellnex consolidates its growth: Organic Revenues up 6%, EBITDAaL up 8.1% and strengthens its financial position through the refinancing of its syndicated loan

    Organic growth in Points of Presence (PoPs) reached 4% YoY, reflecting steady network expansion.

    The company successfully completed a €750 million seven-year bond issuance with a 3.5% coupon, and refinanced a €2.8 billion syndicated credit facility.

    The Group remains committed to its strategic roadmap, prioritising organic and profitable growth, progressive debt reduction, and accelerating shareholder remuneration.

    S&P has improved the rating outlook from stable to positive.

    Barcelona, 31 July 2025.- Cellnex consolidates its growth in the first half of 2025. The company has released its financial results for the first half of 2025, highlighting sustained organic growth across its key operational and financial indicators.

    During this period, in terms of organic growth (including organic revenues generated in the period only and excluding the contribution of Ireland, the foreign exchange market (FX), change of perimeter and others), revenues increased +6% and EBITDAaL +8.1%, reflecting the strength of the underlying business and increased operating leverage. Recurring Leveraged Free Cash Flow (RLFCF) rose to €832 million, compared to €781 million last year that represents a +6.5% increase.  RLFCF per share increased 10.2%. To reinforce its financial capacity, the company successfully completed a €750 million bond issuance and refinanced a €2.8 billion syndicated credit facility, bringing total available liquidity to €4.9 billion. Additionally, Cellnex completed the buyback of 24 million shares, equivalent to 3.41% of its share capital.  Reported revenues reached €1,942 million, compared to €1,921 million in the same period of the previous year, representing a +1.1% increase, impacted by the change of permitter of Austria and Ireland. For its part, EBITDAaL (EBITDA after leases) stood at €1,157 million, up +3.8% from €1,114 million in H1 2024.

    Cellnex reiterates its 2025 guidance: Revenues between €3,950 and €4,050 million, Adjusted EBITDA between €3,275 and €3,375 million, RLFCF between €1,900 and €1,950 million and FCF between €280 and €380 million.

    Marco Patuano, CEO of Cellnex, stated: “The results for the first-half of 2025 consolidate Cellnex’s organic growth trajectory, with sustained improvements in revenues and EBITDAaL”. He added: “The company has strengthened its capital structure through long-term debt issuance and syndicated loan refinancing, significantly enhancing our liquidity and financial flexibility. These actions, combined with disciplined execution of our strategic plan, position us to continue generating recurring value, optimising our risk profile, and accelerating shareholder returns”.

    Industrial consolidation and strategic expansion

    Organic growth in Points of Presence (PoPs) reached +4% YoY, with 1.5% from new colocations at existing sites and 2.5% from new towers deployments, driven primarily by Built-to-Suit (BTS) programs in France and Poland.

    In the second quarter, Cellnex expanded its partnerships with ODIDO in the Netherlands, strengthening a 15-year strategic collaboration and reinforcing its position as a key partner for connectivity and digital transformation.

    Performance by business line

    In H1 2025, the company maintained stable performance across its core business areas:

    • Telecom infrastructure services generated reported revenue €1,568 million, broadly in line with the previous year as a result of the deconsolidation of Ireland and Austria. Excluding the contribution of those countries, the organic revenue growth regarding the Towers business line represented a +5,2% increase.
    • DAS, Small Cells, and network solutionscontributed €126 million, up +2.8%, reflecting growing demand in urban and high-density environments.
    • Wholesale fiber, connectivity, and housing services saw strong growth, reaching €116 million (+20.8%), driven by expansion in other digital infrastructure services.
    • Finally, Broadcasting revenues totalled €132 million, up +2%, reinforcing its role as a complementary business line.

    Site portfolio

    As of 31 July, Cellnex operates 110,310 sites: 88,779 in its five core markets – 26,259 in France, 22,667 in Italy, 17,323 in Poland, 13,691 in the UK and 8,839 in Spain – and 21,531 in the rest of Europe including – 6,729 in Portugal, 5,606 in Switzerland, 4,019 in the Netherlands, 3,459 in Sweden and 1,718 in Denmark –  which are complemented by 1,971 broadcasting and other sites, and 13,858 DAS and Small Cell nodes.

    Financial management, portfolio optimisation, and shareholders return

    In line with its strategy to optimise its operational footprint, Cellnex completed the sale of 100% of its Austrian business in late 2024 to a consortium formed by Vauban Infrastructure Partners, EDF Invest, and MEAG. In February 2025, it finalised the divestment of its Irish operations, acquired by Phoenix Tower International (PTI).

    These strategic decisions support value creation for shareholders, including a share buyback program and a focus on operational efficiency, cash generation, and financial sustainability. On 18 June, Cellnex paid a dividend from share premium totalling €11.82 million, equivalent to €0.0167 per share.

    As of the end of H1 2025, net bank debt stood at €17.1 billion, with a solid structure: 78% fixed-rate, providing stability against market volatility and protecting cash generation capacity.

    Standard & Poor’s Global Ratings (“S&P”) has decided to improve the Cellnex rating outlook from stable to positive. This update comes along greater with flexibility in the thresholds applicable to the Company’s rating. With regards to the current Cellnex rating set at BBB- by S&P, the threshold of the leverage ratio according to the S&P methodology has increased from 6.0x-7.0x to 7.0x-7.75x.

    Commitment to sustainability

    Cellnex continues to advance its decarbonisation strategy, updating its SBTi validated targets and preparing for net-zero emissions validation. For the second consecutive year, Cellnex was ranked among the top 20 most sustainable companies globally (18th overall, 3rd in Spain) by Time and Statista. It was also included again in the S&P Global Sustainability Yearbook 2025, remains in the Dow Jones Europe Index, and received EcoVadis Platinum medal for the second year in a row and is a listed company by CDP and Supplier Engagement Leaderboard for the 6th and 4th consecutive years, recognising its leadership and continuous efforts in sustainability.

     

    About Cellnex Telecom

    Cellnex is Europe’s largest telecommunications towers and infrastructures operator, enabling operators to access a wide network of telecommunications infrastructures on a shared-use basis, and thus helping to reduce access barriers and to improve services in the most remote areas, whilst also contributing to more sustainable deployment. The Company manages a portfolio of more than 110,000 sites, including forecast roll-outs up to 2030, in 10 European countries, with a significant footprint in Spain, France, the United Kingdom, Italy and Poland. Cellnex, which is listed on the Spanish Stock Exchange, is part of the selective IBEX35 and Euro Stoxx 100 and enjoys outstanding positions on the main sustainability indexes such as FTSE4Good, MSCI and DJSI Europe.

    To access both the supporting financial information and the consolidated financial statements, please, visit: Financial Information – Cellnex

     

    Continue Reading

  • Bristol Myers tops revenue expectations on strength of older drugs, shares fall – Reuters

    1. Bristol Myers tops revenue expectations on strength of older drugs, shares fall  Reuters
    2. Bristol Myers touts commercial execution, reckons with recent clinical setbacks  Fierce Pharma
    3. Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top Estimates  Yahoo Finance
    4. Bristol Myers Squibb Reports Second Quarter Financial Results for 2025  BioSpace
    5. Bristol Myers raises revenue guidance for the year, prepares for major Cobenfy readouts  Endpoints News

    Continue Reading

  • RIMOWA unveils new flagship on Madison Avenue in N…

    RIMOWA has unveiled its new flagship store on Madison Avenue in New York City, featuring a striking architectural concept by PORTO Architects, winners of a design competition held by the luggage-maker in 2023-2024.

    The primary challenge was to create a strong identity for RIMOWA on a non-descript modernist building on one of New York’s busiest commercial thoroughfares.  

    The bold statement façade features black porcelain tiles with grooved details inspired by the iconic RIMOWA suitcase design. An impressive side entrance welcomes customers, leading to a double-height interior. The dramatic volume and refined design of the space create an immersive brand experience. A highlight of the store is the ‘range wall’, presenting the complete luggage assortment in a celebration of form, function and innovation. Designed in Germany, the seating area furniture showcases RIMOWA’s German heritage.  

    To celebrate the opening of the new flagship, RIMOWA has unveiled a special limited edition: Original Cabin Monogram New-York-City Exclusive. This version of the iconic Original Cabin features an oversize RIMOWA Monogram in vibrant yellow, a nod to the city’s famous taxis and nightlife. The imprint was created using an innovative technique combining anodization and pigment application. ‘New-York-City exclusive’ is inscribed on the interior label, along with the coordinates of the Madison Avenue store. Made in Cologne, Germany from high-end anodized aluminum, the suitcase has been engineered with longevity in mind, backed by RIMOWA’s lifetime guarantee.  

    Continue Reading

  • Ford renews UKEF support on £1bn loan 

    Ford renews UKEF support on £1bn loan 

    UK Export Finance (UKEF) is partially guaranteeing a £1bn loan to Ford, as the UK government seeks to bolster an automotive sector under pressure from low-cost competitors and US tariffs.  

    Citi is the sole co-ordinator and agent on the loan, which has been syndicated to other lenders. UKEF says it does not have permission to name the other banks on the deal.  

    UKEF is covering 80% of the facility through an export development guarantee, a product that provides general working capital for companies that export from the UK or intend to do so.  

    It is the largest of three guarantees UKEF has furnished for Ford since 2020, and was signed this month, the export credit agency says in a statement.  

    US-headquartered Ford stopped manufacturing vehicles in the UK more than ten years ago. But UKEF says the company still has 5,500 staff in the UK, including at a research and development centre in Essex and an engine and transmission plants in London and Liverpool. 

    Ford Britain chair Lisa Brankin says the loan “will play an important role in supporting our UK exporting footprint, especially amid the continued uncertainty in the trade landscape and the disconnect between electric vehicle targets and customer demand”. 

    UK Chancellor Rachel Reeves said the guarantee “is a major boost for Britain’s auto sector. It will help develop world-leading products, open new export markets, and secure jobs”. 

    Vehicle production fell to a seven-decade low – excluding the Covid-19 pandemic – in the first of half of this year, according to industry group The Society of Motor Manufacturers and Traders, although it expects production to pick up again in 2026. Around eight in 10 cars made in the UK are exported.  

    The first 100,000 UK vehicles exported to the US per year will attract a 10% tariff after the UK and US signed a trade deal earlier this year, up from 2.5% previously. After that quota is met, a tariff of 27.5% will apply.  

    Continue Reading

  • Explore Da Nang’s High-Tech Investment Incentives

    Explore Da Nang’s High-Tech Investment Incentives

    Recent reports indicate that a significant number of high-tech companies have established operations in Da Nang due to a comprehensive set of incentives and special mechanisms. As the main economic hub of Central Vietnam, Da Nang is poised to become a hub for startups and technology firms in Vietnam, fostering an innovation hotspot for a wider region.


    As of July 2025, official statistics show nearly 70 businesses, both international and local, have joined the ecosystem of Da Nang, many of which are well-established firms such as Marvell, Synopsys, Uniquify, Synapse, Savarti (the US), Renesas (Japan), and FPT Semiconductor (Vietnam).

    FIND BUSINESS SUPPORT

    The presence of these leading firms is an affirmation for newcomers of the favorable environment of Da Nang for innovative and high-tech industries, especially the semiconductor, microchip, and artificial intelligence (AI) sectors. This article explores the vibrant business landscape in Da Nang and outlines the key incentives creating the attractiveness of the city, thus examining opportunities for prospective businesses and investors.

    Robust economic growth led by industry and service developments

    According to its latest official socio-economic report, Da Nang continued to witness steady developments across all its socio-economic activities in the first half of 2025, achieving a 10.5 percent growth rate in its gross regional domestic product (GRDP). The industry and construction sectors were the most crucial contributors to this robust performance, asserting a 11.3 percent increase, followed by a 10.2 percent growth of the service industries and a 2.7 percent increase of agriculture, forestry, and fisheries.

    chart visualization

    This growth trend aligns with the city’s trajectory of economic structure shift, which revolves around three main pillars of tourism, high-tech industries, and the marine economy. In the first half of 2025, the city reported upbeat results in several key performance indices demonstrating its growing industrial strength, such as:

    • Achieving a US$1.76 billion trade turnover, a 10.9 percent increase year over year;
    • Recording a US$997.5 million export turnover, a 7.1 percent increase year over year;
    • Total logistics revenue reaching US$11.47 trillion in the first five months of 2025, a 16.4 percent increase compared to the same period last year;
    • Total capital mobilization by credit institutions in the city reaching VND 237 trillion (US$9.05 million) by the end of May 2025, a 7.52 percent rise from the end of 2024;
    • The industrial sector contributing approximately 11.8 percent to GRDP; and
    • The estimated industrial production index (IIP) growth for the first five months of 2025 reaching 11.81 percent year-over-year.

    This strong performance showcases the city’s ability to meet its strategic goals consistently, providing much-needed stability to foster long-term development for businesses.

    Rapidly enhanced supporting infrastructure for high-tech sector

    To bolster its goal of becoming a regional innovation hub, Da Nang is speeding up the development of key infrastructures for high-tech incubation. Major corporations are positioning Da Nang as a national hotspot for science and technology development, with key projects such as the semiconductor Lab-Fab facility led by VSAP LAB, valued at VND 1.8 trillion (US$68.73 million) and expected to launch in January 2026.

    FIND BUSINESS SUPPORT

    Da Nang’s high-tech park is set to host a large-scale data center project backed by the International Data Center Corporation. With nearly VND 800 billion (US$30.54 million) in investment and 1,000 server racks, the facility is expected to become a regional data hub with advanced technology solutions. The project offers startups and research and development (R&D) teams access to shared infrastructure, coworking facilities, and incubation resources, enhancing the city’s appeal as a national center for innovation.

    The city is also upgrading its Biotechnology Center with modern lab equipment to support advanced research in genetics, food technology, bio-processing, and smart agriculture, contributing to a more diversified tech ecosystem.

    Ambitious targets to build a high-skilled, competitive workforce

    Da Nang is pursuing a strategic shift in human capital planning with the goal of cultivating over 300,000 high-quality workers. Its emphasis is on advanced technical skills, digital fluency, and international readiness. By aiming to certify more than 85 percent of the workforce, the city intends to move from cost-driven growth to development driven by productivity and innovation.

    This approach is vital for attracting investment in sectors like digital finance, smart logistics, creative industries, and green technologies. Da Nang has ambitious plans to establish a permanent community of over 5,000 experts, including 1,000 foreign professionals, to support the city’s transformation into a regional innovation hub.

    A vibrant entrepreneurial ecosystem is already on the horizon, with plans to have 3,000 startups, 50,000 private firms, and 300 globally-minded entrepreneurs by 2035.

    Targeted incentives to accelerate high-tech investments in Da Nang

    Experts believe Da Nang’s economic and industrial strengths are greatly enhanced by the special mechanisms and incentives provided by the city. These supportive policies are issued under the National Assembly’s Resolution No. 136/2024/QH15. The resolution, which outlines the pilot implementation of several special mechanisms and policies for Da Nang’s development, is an important regulatory framework for prospective investors and businesses to explore the benefits they might gain when participating in the city’s dynamic ecosystem.

    Priority sectors and investment thresholds

    According to the resolution, Da Nang prioritizes strategic investments in the following sectors, with minimum capital requirements ranging from VND 2 to 45 trillion (approx. US$76.34 million to US$1.72 billion):

    • Innovation infrastructure, including R&D, data centers, and hi-tech transfer;
    • Semiconductors and advanced electronics, including integrated circuits (ICs), printed electronics, and batteries;
    • Free Trade Zone (FTZ) development, encompassing logistics, manufacturing, and trade services; and
    • Tourism and seaport infrastructure, including inland waterways and the Lien Chieu Seaport.

    Strategic Investor Eligibility Requirements

    Investor Requirement

    Applicable Project Types

    • Charter capital ≥ VND 500 billion (US$19 million); and
    • Experience in similar projects with total investment ≥ VND 1 trillion (US$38.17 milllion).
    • Investment in innovation centers, data centers, R&D centers (linked with training), and high-tech transfer in IT, AI, biotech, automation, new materials, and clean energy; and
    • Minimum project capital: VND 2 trillion.
    • Charter capital ≥ VND 1 trillion; and
    • Experience in similar projects with total investment ≥ VND 2  trillion.
    • Investment in semiconductors,  ICs, printed electronics (PEs), new battery technologies, and high-tech products approved by the Prime Minister;
    • Infrastructure development in Da Nang FTZ, including commercial-service zones, logistics centers (Lien Chieu Port), and production zones; and
    • Minimum project capital: VND 34 trillion (US$115-153 million).
    • Charter capital ≥ VND 2  trillion; and
    • Experience in similar projects with total investment ≥ VND 2 trillion.
    • Investment in inland waterway tourism infrastructure; and
    • Minimum project capital: VND 8 trillion (US$305 million).
    • Charter capital ≥ VND 9 trillion (US$344 million); and
    • Experience in similar projects with total investment ≥ VND 25 trillion (US$954 million).
    • Investment in the master project for Lien Chieu Seaport; and
    • Minimum project capital: VND 45 trillion (US$1.72 billion).

    Source: Resolution No. 136/2024/QH15

    Land access and project selection mechanisms

    Investors in semiconductor, AI, and related sectors may obtain land through:

    • Direct allocation or auction, based on project approval route; or
    • Bid-based selection, where multiple qualified investors exist.

    Investment authorities will manage disclosure, registration, and investor screening processes through the Vietnam E-Procurement System.

    Tax incentives and financial support in Da Nang

    Eligible entities may benefit from corporate income tax (CIT) and personal income tax (PIT) Relief, including:

    • CIT exemption for 5 years for startups and support organizations in semiconductors, AI, and innovation;
    • PIT and CIT exemption on capital gains for investors in unlisted startups; and
    • PIT exemption for skilled professionals in semiconductor and AI roles, for 5 years.

    FIND BUSINESS SUPPORT

    Additionally, strategic investors are entitled to R&D and customs prioritization, such as:

    • 150 percent deduction of R&D costs against taxable income; and
    • Priority handling in customs and tax procedures, subject to conditions.

    Regulatory sandbox model for testing of emerging technologies

    Da Nang may approve up to three-year test periods for new technologies and business models in hi-tech parks and innovation centers, which can be renewed once. The supporting policies for this include:

    • Testing entities might be exempt from civil or administrative liability under certain conditions; and
    • City agencies are tasked with monitoring, providing feedback, and making regulatory adjustments.

    Scientific and technological asset management

    Publicly funded infrastructure, such as co-working spaces, R&D laboratories, and shared equipment, may be leased without auction to eligible startups and support entities. In addition, the City Budget may subsidize usage costs and provide funding for training programs aimed at users of these assets.

    Semiconductor and AI sector-specific incentives

    Da Nang offers additional support to semiconductor and AI firms:

    • Direct contracting for equipment procurement;
    • 5 percent cost support for equipment, relocation, or new investments;
    • Subsidies for high-skilled personnel, including relocation and retention bonuses; and
    • Training support for students and professionals in relevant fields.

    Salary and income mechanisms

    FIND BUSINESS SUPPORT

    Under Resolution 136, Da Nang can adopt flexible income policies to attract and retain top talent in key sectors. The city may increase salaries for public officials and government staff by up to 80 percent of the base salary fund, depending on performance.

    In parallel, tailored income schemes are being developed for scientists, technical specialists, and high-skilled professionals working in strategic fields such as semiconductors, AI, and digital infrastructure. These policies aim to enhance the competitiveness of the local workforce and align with the city’s broader innovation agenda.

    See also: Da Nang Free Trade Zone: Implementation Plan, Incentives, and Investment Opportunities

    Takeaway for businesses

    Da Nang is rapidly positioning itself as a premier destination for high-tech investment in Vietnam, underpinned by targeted incentives, expanding infrastructure, and a strategic focus on semiconductor, AI, and digital technologies.

    Businesses operating in innovation-related sectors can benefit from generous tax exemptions, prioritized land access, and talent-focused subsidies. With robust economic momentum, dedicated support for R&D, and streamlined regulatory pathways, Da Nang presents a compelling opportunity for tech-driven enterprises looking to enter or expand in Vietnam’s emerging innovation corridor.

    (US$1 = VND 26.199)

    About Us

    Vietnam Briefing is published by Asia Briefing, a subsidiary of Dezan Shira & Associates. We produce material for foreign investors throughout Asia, including ASEAN, China, and India. For editorial matters, contact us here and for a complimentary subscription to our products, please click here. For assistance with investments into Vietnam, please contact us at vietnam@dezshira.com or visit us at www.dezshira.com.

    Dezan Shira & Associates assists foreign investors throughout Asia from offices across the world, including in Hanoi, Ho Chi Minh City, and Da Nang. We also maintain offices or have alliance partners assisting foreign investors in China, Hong Kong SAR, Dubai (UAE), Indonesia, Singapore, Philippines, Malaysia, Thailand, Bangladesh, Italy, Germany, the United States, and Australia.

     

    Continue Reading

  • Asciminib Nets Canadian Approval in Newly Diagnosed and Previously Treated Ph+ CML

    Asciminib Nets Canadian Approval in Newly Diagnosed and Previously Treated Ph+ CML

    Newly Diagnosed Ph+ CML | Image credit:

    © Brighting Collection – stock.adobe.com

    Asciminib (Scemblix) has received a Notice of Compliance from Health Canada for the treatment of adult patients with Philadelphia chromosome (Ph)–positive chronic myeloid leukemia (CML) in chronic phase (CP-CML) in the newly diagnosed setting or following treatment with at least 1 TKI.1

    The regulatory decision was supported by data from the phase 3 ASC4FIRST trial (NCT04971226), which compared asciminib withan investigator-selected TKI in patients with newly diagnosed CML.2 Findings from the study showed that patients who received
    asciminib (n = 201) achieved a major molecular response (MMR) rate of 68% (95% CI, 61%-74%) compared with 49% (95% CI, 42%-56%) among patients who received imatinib (Gleevec), nilotinib (Tasigna), dasatinib (Sprycel), or bosutinib (Bosulif; n = 204), translating to a difference of 19% (95% CI, 10%-28%; P < .001).3 The 48-week MMR rates in the asciminib and investigator-selected TKI arms were 66% (95% CI, 56%-75%) and 58% (95% CI, 48%-68%), respectively, representing an estimated difference of 8.17% (95% CI, –5.14% to 21.47%).

    “The approval of asciminib represents a significant step forward, expanding treatment options for [patients with] CML,” Dennis Kim, MD, PhD, a clinician investigator in the Princess Margaret Cancer Centre Cancer Clinical Research Unit at Princess Margaret Cancer Centre in Toronto, Canada, stated in a news release.1 “Having a diverse range of therapies available allows care teams to keep the unique needs of the patient at the center of treatment plans, optimizing outcomes. The ability to prescribe asciminib to newly diagnosed and previously treated patients offers a promising new pathway in our efforts to manage this complex disease effectively and safely.”

    In October 2024, the FDA granted accelerated approval to asciminib for the treatment of adult patients with newly diagnosed, Ph-positive CP-CML, based on data from ASC4FIRST.4

    ASC4FIRST was a multicenter, open-label study that enrolled adult patients with newly diagnosed, previously untreated patients with Ph-positive CML in chronic phase.5 Eligible patients were required to be enrolled onto the study within 3 months of diagnosis, have an ECOG performance status of 0 or 1, and have adequate organ function. Patients also needed to have less than 15% of blasts in peripheral blood and bone marrow, less than 30% blasts plus promyelocytes in peripheral blood and bone marrow, less than 20% basophils in the peripheral blood, and a platelet count of at least 100 x 109/L.

    Patients were randomly assigned 1:1 to receive oral asciminib at 80 mg once daily or an investigator-selected TKI. In the control arm, patients were treated with daily imatinib at 400 mg, twice daily nilotinib at 300 mg, daily dasatinib at 100 mg, or daily bosotunib at 400 mg.

    The primary end point was MMR rate. Secondary end points included 96-week MMR rate, time to discontinuation of study treatment due to adverse effects (AEs), MMR at other scheduled time points, duration of MMR, complete cytogenic response rate, and time to treatment failure.

    In terms of safety, the most common any-grade AEs occurring in at least 20% of patients in the investigational arm included musculoskeletal pain (33%), thrombocytopenia (28%), fatigue (25%), upper respiratory tract infections (24%), headache (22%), neutropenia (22%), and diarrhea (20%).3 The most common grade 3 or higher AEs that were reported in at least 5% of patients included thrombocytopenia (17%), neutropenia (14%), increased pancreatic enzymes (9%), and hypertension (9%). Serious AEs were reported in 10% of patients; common serious AEs occurring in at least 1% of patients included pleural effusion (2%), lower respiratory tract infections (1%), thrombocytopenia (1%), pancreatitis (1%), and pyrexia (1%).

    “We are proud that Health Canada has expanded its approval of [asciminib], making it a new option for all Canadians with [Ph-positive] CML, whether they are newly diagnosed or have been previously treated,” Mark Vineis, country president, Novartis Canada, added in the news release.1 “This approval means patients and their physicians now have more choices when deciding on the best course of treatment, offering renewed hope for individuals living with CML, their families, and the health care teams dedicated to their care.”

    References

    1. Health Canada expands approval of Scemblix, making it an option for newly diagnosed and previously treated chronic myeloid leukemia (CML) patients. News release. Novartis. July 30, 2025. Accessed July 31, 2025. https://www.novartis.com/ca-en/news/media-releases/health-canada-expands-approval-scemblix-making-it-option-newly-diagnosed-and-previously-treated-chronic-myeloid-leukemia-cml-patients
    2. Hochhaus A, Wang J, Kim DW, et al. Asciminib in newly diagnosed chronic myeloid leukemia. N Engl J Med. 2024;391(10):885-898. doi:10.1056/NEJMoa2400858
    3. Scemblix. Product monograph. July 25, 2025. Accessed July 31, 2025. https://www.novartis.com/ca-en/sites/novartis_ca/files/scemblix_pm_20250725_en.pdf
    4. FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemia. FDA. October 29, 2024. Accessed July 31, 2025. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-asciminib-newly-diagnosed-chronic-myeloid-leukemia
    5. A study of oral asciminib versus other TKIs in adult patients with newly diagnosed Ph+ CML-CP. ClinicalTrials.gov. Updated July 31, 2025. Accessed July 31, 2025. https://clinicaltrials.gov/study/NCT04971226

    Continue Reading